VCU Massey Cancer Center


Massey member directory

For members: update your profile »

« Back to member list

Youngman Oh, M.S., Ph.D.

Massey Cancer Center research program membership

Developmental Therapeutics

Department affiliations

Professor, Department of Pathology, School of Medicine


PhD, Stanford University (1993)
MS, Eastern Michigan University (1987)

Research description

My laboratory has discovered an entirely distinct anti-tumor and anti-metastatic signaling pathway through a new class of cell death receptor, known as TMEM219. We have further obtained two monoclonal antibodies (mAbs) that activate the TMEM219 receptor, so-called "agonistic antibodies." Currently, my laboratory focuses on therapeutic potential of those TMEM219 mAbs as a monotherapy or a combinational therapy with chemodrugs and immune checkpoint inhibitors in breast, lung, colon, and pancreatic cancer and AML.

Disease focus of research

Breast, Hematologic Malignancies, Prostate, Colorectal, Hepatic, Pancreatic

Research keywords

Angiogenesis,Animal models,Apoptosis,Biomarkers,Cancer cell biology,Cancer therapy resistance,Cell signaling,Drug discovery,Immunotherapy,Inflammation,Obesity,Signal transduction,Targeted therapies,Translational science

Published research (during tenure as a Massey Cancer Center member)

Search In PubMed

Contact information


View graphic version